014 ULTRAFILTRATION: A NEW THERAPEUTIC OPTION FOR UK PATIENTS WITH END-STAGE HEART FAILURE
نویسندگان
چکیده
منابع مشابه
Peritoneal ultrafiltration in end-stage congestive heart failure.
Congestive heart failure (CHF) refractory to pharmacological therapy is a growing medical problem. Renal sodium and water retention remains a key event in the pathogenesis of the disease progression and episodes of severe cardiac decompensation, being also the leading cause of high hospitalization rates and an important risk factor for worsening kidney function and chronic kidney disease (CKD)....
متن کاملPeritoneal ultrafiltration in end-stage chronic heart failure
BACKGROUND Cardiorenal syndrome type 2 (CRS-2) is common in end-stage chronic heart failure (CHF). Peritoneal ultrafiltration (pUF) may entail clinical functional improvement and a reduction in hospitalizations. METHODS Thirty-nine consecutive end-stage CHF patients with stable CRS-2 were initiated on ambulatory pUF after interdisciplinary cardiological/nephrological evaluation and prospectiv...
متن کاملHome peritoneal ultrafiltration in patients with severe congestive heart failure without end-stage renal disease.
Congestive heart failure (CHF), mainly because of ischemic heart disease, is becoming a common medical problem. As CHF worsens and reaches New York Heart Association (NYHA) class IV, many patients can become refractory to medical therapy, especially those who are elderly or who have pre-existing non uremic chronic renal failure. For such patients, quality of life, morbidity, and mortality are e...
متن کاملSoluble Adiponectin is a New Predictor for Cardiovascular Complications in Patients with End Stage Renal Disease
Mortality due to cardiovascular complications (CVC) in patients with end stage renal disease (ESRD) is 20 fold higher than in general population. Adiponectin (ADPN) hormone from adipose tissues accumulation in serum is attributed to reduced renal clearance. The aim of this study was to investigate the possible role of ADPN as a predictor of CVC in adult patients with ESRD on hemodialysis (HD), ...
متن کاملImplantable left ventricular assist devices: new hope for patients with end-stage heart failure.
INTRODUCTION Recently, the Food and Drug Administration approved implantable left ventricular assist devices (LVAD) as destination therapy (DT) for end-stage heart failure patients who are ineligible for cardiac transplantation. OBJECTIVE AND STUDY DESIGN This is a case series that describes the early results with DT LVAD at Duke University Medical Center (DUMC). An additional objective is to...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Heart
سال: 2013
ISSN: 1355-6037,1468-201X
DOI: 10.1136/heartjnl-2013-304019.14